Acquired resistance to tyrosine kinase inhibitors (TKIs) in gastrointestinal stromal tumours (GISTs) is most commonly caused by secondary KIT or PDGFRA mutations. The gene discussed is PDGFRA; the disease is gastrointestinal stromal tumor.